Skip to main content

Table 2 Details and sources of primary data collection

From: Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia

Parameters Components Sources of data Number of patients
Direct medical cost Number of hospital admissions/outpatient visits Patient interviews 48 (FC I = 18, FC II = 19, FC III = 10, FC IV = 1)
Hospital admission and outpatient visit costs e.g. other drug cost, laboratory services, etc. Hospital billing
Cost of pulmonary selective drugs Cost of sildenafil and beraprost Hospital billing
Direct non-medical cost Travel, consumption, accommodation expenses, opportunity cost of caregivers, cost of daily supportive devices Patient interviews
Utility Patient interviews